| Zugriffe | |
|---|---|
| Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study | 105 |
| Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study | 1 | 1 | 3 | 0 | 1 | 2 | 14 |
| Zugriffe | |
|---|---|
| 2020_Belyavskiy_etal.pdf | 73 |
